DOACs in Patients With Mitral Stenosis and A-fib: Analysis Suggests a Benefit

March 12, 2019

Patients with mitral stenosis and A-fib appear to do better when they receive direct oral anticoagulants (DOACs) instead of warfarin, an observational analysis suggests. The data, while not randomized, offer insight into an important patient group, one which was largely excluded from the trials that first brought DOACs to market, experts say.